Placebo to AIN457 150 mg/1 mL Solution for injection in pre-filled syringe, SECUKINUMAB
CAIN457I2401
Approved small_molecule active
Quick answer
Placebo to AIN457 150 mg/1 mL Solution for injection in pre-filled syringe, SECUKINUMAB for non-radiographic axial spondyloarthritis is a Approved program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- non-radiographic axial spondyloarthritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active